CanSense
Pre-clinicalColorectal cancer, also known as bowel cancer, is the third most common cancer globally. It is responsible for around 10% of all cancer diagnoses and is the second leading cause of cancer-related deaths worldwide.
Founded
2017
Focus
Diagnostics
About
Colorectal cancer, also known as bowel cancer, is the third most common cancer globally. It is responsible for around 10% of all cancer diagnoses and is the second leading cause of cancer-related deaths worldwide.
Funding History
3Total raised: $3.5M
Seed$1.5MDevelopment Bank of WalesJun 15, 2022
Seed$1.5MDevelopment Bank of WalesJun 15, 2022
Grant$500KInnovate UKMar 15, 2021
Company Info
TypePrivate
Founded2017
LocationSwansea, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile